A Review of the Pharmacological Properties of Psoralen

Psoralen is the principal bioactive component in the dried fruits of Cullen corylifolium (L.) Medik (syn. Psoralea corylifolia L), termed “Buguzhi” in traditional Chinese medicine (TCM). Recent studies have demonstrated that psoralen displays multiple bioactive properties, beneficial for the treatme...

Full description

Bibliographic Details
Main Authors: Yali Ren, Xiaominting Song, Lu Tan, Chuanjie Guo, Miao Wang, Hui Liu, Zhixing Cao, Yuzhi Li, Cheng Peng
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.571535/full
id doaj-18082cadcf6a4a18a9fbefedf91e897b
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Yali Ren
Xiaominting Song
Lu Tan
Chuanjie Guo
Miao Wang
Hui Liu
Zhixing Cao
Yuzhi Li
Cheng Peng
spellingShingle Yali Ren
Xiaominting Song
Lu Tan
Chuanjie Guo
Miao Wang
Hui Liu
Zhixing Cao
Yuzhi Li
Cheng Peng
A Review of the Pharmacological Properties of Psoralen
Frontiers in Pharmacology
psoralen
osteoporosis
tumor
inflammatory
Severe Acute Respiratory Syndrome Coronavirus 2
author_facet Yali Ren
Xiaominting Song
Lu Tan
Chuanjie Guo
Miao Wang
Hui Liu
Zhixing Cao
Yuzhi Li
Cheng Peng
author_sort Yali Ren
title A Review of the Pharmacological Properties of Psoralen
title_short A Review of the Pharmacological Properties of Psoralen
title_full A Review of the Pharmacological Properties of Psoralen
title_fullStr A Review of the Pharmacological Properties of Psoralen
title_full_unstemmed A Review of the Pharmacological Properties of Psoralen
title_sort review of the pharmacological properties of psoralen
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2020-09-01
description Psoralen is the principal bioactive component in the dried fruits of Cullen corylifolium (L.) Medik (syn. Psoralea corylifolia L), termed “Buguzhi” in traditional Chinese medicine (TCM). Recent studies have demonstrated that psoralen displays multiple bioactive properties, beneficial for the treatment of osteoporosis, tumors, viruses, bacteria, and inflammation. The present review focuses on the research evidence relating to the properties of psoralen gathered over recent years. Firstly, multiple studies have demonstrated that psoralen exerts strong anti-osteoporotic effects via regulation of osteoblast/osteoclast/chondrocyte differentiation or activation due to the participation in multiple molecular mechanisms of the wnt/β-catenin, bone morphogenetic protein (BMP), inositol-requiring enzyme 1 (IRE1)/apoptosis signaling kinase 1 (ASK1)/c-jun N-terminal kinase (JNK) and the Protein Kinase B(AKT)/activator protein-1 (AP-1) axis, and the expression of miR-488, peroxisome proliferators-activated receptor-gamma (PPARγ), and matrix metalloproteinases (MMPs). In addition, the antitumor properties of psoralen are associated with the induction of ER stress-related cell death via enhancement of PERK: Pancreatic Endoplasmic Reticulum Kinase (PERK)/activating transcription factor (ATF), 78kD glucose-regulated protein (GRP78)/C/EBP homologous protein (CHOP), and 94kD glucose-regulated protein (GRP94)/CHOP signaling, and inhibition of P-glycoprotein (P-gp) or ATPase that overcomes multidrug resistance. Furthermore, multiple articles have shown that the antibacterial, anti-inflammatory and neuroprotective effects of psoralen are a result of its interaction with viral polymerase (Pol), destroying the formation of biofilm, and regulating the activation of tumor necrosis factor alpha (TNF-α), transforming growth factor beta (TGF-β), interleukin 4/5/6/8/12/13 (IL-4/5/6/8/12/13), GATA-3, acetylcholinesterase (AChE), and the hypothalamic-pituitary-adrenal (HPA) axis. Finally, the toxic effects and mechanisms of action of psoralen have also been reviewed.
topic psoralen
osteoporosis
tumor
inflammatory
Severe Acute Respiratory Syndrome Coronavirus 2
url https://www.frontiersin.org/article/10.3389/fphar.2020.571535/full
work_keys_str_mv AT yaliren areviewofthepharmacologicalpropertiesofpsoralen
AT xiaomintingsong areviewofthepharmacologicalpropertiesofpsoralen
AT lutan areviewofthepharmacologicalpropertiesofpsoralen
AT chuanjieguo areviewofthepharmacologicalpropertiesofpsoralen
AT miaowang areviewofthepharmacologicalpropertiesofpsoralen
AT huiliu areviewofthepharmacologicalpropertiesofpsoralen
AT zhixingcao areviewofthepharmacologicalpropertiesofpsoralen
AT yuzhili areviewofthepharmacologicalpropertiesofpsoralen
AT chengpeng areviewofthepharmacologicalpropertiesofpsoralen
AT yaliren reviewofthepharmacologicalpropertiesofpsoralen
AT xiaomintingsong reviewofthepharmacologicalpropertiesofpsoralen
AT lutan reviewofthepharmacologicalpropertiesofpsoralen
AT chuanjieguo reviewofthepharmacologicalpropertiesofpsoralen
AT miaowang reviewofthepharmacologicalpropertiesofpsoralen
AT huiliu reviewofthepharmacologicalpropertiesofpsoralen
AT zhixingcao reviewofthepharmacologicalpropertiesofpsoralen
AT yuzhili reviewofthepharmacologicalpropertiesofpsoralen
AT chengpeng reviewofthepharmacologicalpropertiesofpsoralen
_version_ 1724597750048227328
spelling doaj-18082cadcf6a4a18a9fbefedf91e897b2020-11-25T03:25:18ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-09-011110.3389/fphar.2020.571535571535A Review of the Pharmacological Properties of PsoralenYali Ren0Xiaominting Song1Lu Tan2Chuanjie Guo3Miao Wang4Hui Liu5Zhixing Cao6Yuzhi Li7Cheng Peng8School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, National Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu, ChinaSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, National Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu, ChinaSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, National Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu, ChinaSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, National Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu, ChinaSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, National Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu, ChinaJiangsu Key Laboratory of Drug Discovery for Metabolic Disease, China, Pharmaceutical University, Nanjing, ChinaSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, National Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu, ChinaSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, National Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu, ChinaSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, National Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu, ChinaPsoralen is the principal bioactive component in the dried fruits of Cullen corylifolium (L.) Medik (syn. Psoralea corylifolia L), termed “Buguzhi” in traditional Chinese medicine (TCM). Recent studies have demonstrated that psoralen displays multiple bioactive properties, beneficial for the treatment of osteoporosis, tumors, viruses, bacteria, and inflammation. The present review focuses on the research evidence relating to the properties of psoralen gathered over recent years. Firstly, multiple studies have demonstrated that psoralen exerts strong anti-osteoporotic effects via regulation of osteoblast/osteoclast/chondrocyte differentiation or activation due to the participation in multiple molecular mechanisms of the wnt/β-catenin, bone morphogenetic protein (BMP), inositol-requiring enzyme 1 (IRE1)/apoptosis signaling kinase 1 (ASK1)/c-jun N-terminal kinase (JNK) and the Protein Kinase B(AKT)/activator protein-1 (AP-1) axis, and the expression of miR-488, peroxisome proliferators-activated receptor-gamma (PPARγ), and matrix metalloproteinases (MMPs). In addition, the antitumor properties of psoralen are associated with the induction of ER stress-related cell death via enhancement of PERK: Pancreatic Endoplasmic Reticulum Kinase (PERK)/activating transcription factor (ATF), 78kD glucose-regulated protein (GRP78)/C/EBP homologous protein (CHOP), and 94kD glucose-regulated protein (GRP94)/CHOP signaling, and inhibition of P-glycoprotein (P-gp) or ATPase that overcomes multidrug resistance. Furthermore, multiple articles have shown that the antibacterial, anti-inflammatory and neuroprotective effects of psoralen are a result of its interaction with viral polymerase (Pol), destroying the formation of biofilm, and regulating the activation of tumor necrosis factor alpha (TNF-α), transforming growth factor beta (TGF-β), interleukin 4/5/6/8/12/13 (IL-4/5/6/8/12/13), GATA-3, acetylcholinesterase (AChE), and the hypothalamic-pituitary-adrenal (HPA) axis. Finally, the toxic effects and mechanisms of action of psoralen have also been reviewed.https://www.frontiersin.org/article/10.3389/fphar.2020.571535/fullpsoralenosteoporosistumorinflammatorySevere Acute Respiratory Syndrome Coronavirus 2